rhNRG-1 and rhErbB3-f were Selected to “Shanghai Sci & Tech Prosperity Program” and “Huiyan Program”
2006-01-05
In December 2005, Zensun’s two proprietary research projects - recombinant human Neuregulin-1 and recombinant human ErbB3 fragment (rhErbB3-f) immunization, were officially selected “Shanghai Sci & Tech Prosperity Program” and “Huiyan Program”
更多动态
Zensun is Collaborating with The Leibniz-Institut für Alternsforschung-Fritz-Lipmann-Institute.V. to Conduct a Preclinical Study of Neucardin® (recombinant human Neuregulin-1) for The Treatment of Schwannomas
ZENSUN ANNOUNCES THE INVESTIGATION OF NEUCARDIN FOR CHRONIC HEART FAILURE RECEIVES FAST TRACK DESIGNATION FROM THE US FDA
An International Multi-center Phase III Clinical Trial of Recombinant Human Neuregulin-1 is going to
